Syndax Pharmaceuticals Inc - SNDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Head of R&D, CMO | M | A | 31,235.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 12, 2026 | Head of R&D, CMO | M | A | 22,515.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 12, 2026 | Head of R&D, CMO | S | D | 31,235.0 | 18.14 | 566,602.9 | 60,885.0 | View | |
| Jun 12, 2026 | Head of R&D, CMO | M | A | 31,235.0 | 13.82 | 431,667.7 | 92,120.0 | View | |
| Jun 12, 2026 | Head of R&D, CMO | S | D | 34,280.0 | 18.0 | 617,040.0 | 60,885.0 | View | |
| Jun 12, 2026 | Head of R&D, CMO | M | A | 22,515.0 | 13.82 | 311,157.3 | 95,165.0 | View | |
| Jun 02, 2026 | Chief Financial Officer | S | D | 1,177.0 | 18.99 | 22,351.23 | 139,252.0 | View | |
| Jun 02, 2026 | Chief Executive Officer | S | D | 6,847.0 | 18.99 | 130,024.53 | 484,843.0 | View | |
| Feb 10, 2026 | Chief Executive Officer | S | D | 17,159.0 | 21.028 | 360,819.45 | 491,690.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | S | D | 3,410.0 | 21.028 | 71,705.48 | 140,429.0 | View | |
| Feb 06, 2026 | Chief Executive Officer | A | A | 440,000.0 | 20.43 | 8,989,200.0 | 440,000.0 | View | |
| Feb 06, 2026 | Chief Executive Officer | S | D | 7,412.0 | 20.62 | 152,835.44 | 508,849.0 | View | |
| Feb 06, 2026 | Chief Executive Officer | A | A | 144,600.0 | 0.0 | 0.0 | 516,261.0 | View | |
| Feb 06, 2026 | Chief Executive Officer | A | A | 73,000.0 | 0.0 | 0.0 | 371,661.0 | View | |
| Feb 06, 2026 | Chief Financial Officer | A | A | 118,000.0 | 20.43 | 2,410,740.0 | 118,000.0 | View | |
| Feb 06, 2026 | Chief Financial Officer | S | D | 2,082.0 | 20.62 | 42,930.84 | 143,839.0 | View | |
| Feb 06, 2026 | Chief Financial Officer | A | A | 30,750.0 | 0.0 | 0.0 | 145,921.0 | View | |
| Feb 06, 2026 | Chief Financial Officer | A | A | 21,500.0 | 0.0 | 0.0 | 115,171.0 | View | |
| Feb 06, 2026 | Chief Financial Officer | J | A | 1,219.0 | 8.48 | 10,337.12 | 93,671.0 | View | |
| Feb 06, 2026 | — | A | A | 24,000.0 | 0.0 | 0.0 | 114,000.0 | View | |
| Feb 06, 2026 | — | A | A | 24,000.0 | 0.0 | 0.0 | 103,000.0 | View | |
| Feb 06, 2026 | Head of R&D, CMO | A | A | 144,700.0 | 20.43 | 2,956,221.0 | 144,700.0 | View | |
| Feb 06, 2026 | Head of R&D, CMO | A | A | 36,000.0 | 0.0 | 0.0 | 95,165.0 | View | |
| Feb 06, 2026 | Head of R&D, CMO | A | A | 24,000.0 | 0.0 | 0.0 | 59,165.0 | View | |
| Feb 06, 2026 | — | A | A | 48,000.0 | 0.0 | 0.0 | 239,763.0 | View | |
| Feb 06, 2026 | — | A | A | 24,000.0 | 0.0 | 0.0 | 49,000.0 | View | |
| Feb 06, 2026 | — | A | A | 24,000.0 | 0.0 | 0.0 | 124,000.0 | View | |
| Feb 06, 2026 | — | A | A | 24,000.0 | 0.0 | 0.0 | 114,000.0 | View |